Clinical value of macrogenome next-generation sequencing on infections

IF 1.7 4区 生物学 Q3 BIOLOGY Open Life Sciences Pub Date : 2024-09-09 DOI:10.1515/biol-2022-0938
Benfa Han, Xiaoli Zhang, Xiuxi Li, Mei Chen, Yanlin Ma, Yunxia Zhang, Song Huo
{"title":"Clinical value of macrogenome next-generation sequencing on infections","authors":"Benfa Han, Xiaoli Zhang, Xiuxi Li, Mei Chen, Yanlin Ma, Yunxia Zhang, Song Huo","doi":"10.1515/biol-2022-0938","DOIUrl":null,"url":null,"abstract":"Intracranial infection (ICI) is a frequent and serious complication after neurosurgery. Macrogenome next-generation sequencing (mNGS) technology can provide reference for clinical diagnosis and treatment of ICI. This work aimed to explore the application value of mNGS technology in analyzing the clinical characteristics of human immunodeficiency virus (HIV) infection and ICI after neurosurgery. A total of 60 patients with ICI were enrolled as the research objects, all patients underwent routine cerebrospinal fluid analysis and traditional pathogen detection, followed by mNGS genome analysis. Using clinical diagnosis of ICI as the gold standard, the sensitivity, specificity, positive predictive value, and negative predictive value for both detection methods were calculated. Receiver operating characteristic curves were constructed to assess the area under the curve (AUC) for evaluating the clinical value of mNGS in suspected intracranial infectious pathogen diagnosis. Results showed a positivity rate of 71.67% (43 cases) with mNGS compared to 28.33% (17 cases) with traditional pathogen detection methods, demonstrating a significant difference (<jats:italic>P</jats:italic> &lt; 0.05). The sensitivity of mNGS for detecting ICIs was 83.7%, significantly higher than the 34.88% observed with traditional methods (<jats:italic>P</jats:italic> &lt; 0.05). The pathogen detection rate of mNGS was higher than traditional methods (<jats:italic>P</jats:italic> = 0.002), with an AUC of 0.856 (95% CI: 0.638–0.967), significantly greater than the AUC of 0.572 (95% CI: 0.350–0.792) for traditional methods (<jats:italic>P</jats:italic> &lt; 0.05). mNGS successfully identified microorganisms such as <jats:italic>Cryptococcus</jats:italic>, <jats:italic>Propionibacterium</jats:italic>, <jats:italic>Staphylococcus</jats:italic>, <jats:italic>Corynebacterium</jats:italic>, <jats:italic>Micrococcus</jats:italic>, and <jats:italic>Candida</jats:italic> associated with ICIs. These findings underscore the clinical applicability of mNGS technology in analyzing the characteristics of HIV infection and ICI post-neurosurgical procedures. This technology enables more accurate diagnosis and treatment of ICIs, providing valuable insights for developing effective therapeutic strategies.","PeriodicalId":19605,"journal":{"name":"Open Life Sciences","volume":"23 1","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Life Sciences","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1515/biol-2022-0938","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Intracranial infection (ICI) is a frequent and serious complication after neurosurgery. Macrogenome next-generation sequencing (mNGS) technology can provide reference for clinical diagnosis and treatment of ICI. This work aimed to explore the application value of mNGS technology in analyzing the clinical characteristics of human immunodeficiency virus (HIV) infection and ICI after neurosurgery. A total of 60 patients with ICI were enrolled as the research objects, all patients underwent routine cerebrospinal fluid analysis and traditional pathogen detection, followed by mNGS genome analysis. Using clinical diagnosis of ICI as the gold standard, the sensitivity, specificity, positive predictive value, and negative predictive value for both detection methods were calculated. Receiver operating characteristic curves were constructed to assess the area under the curve (AUC) for evaluating the clinical value of mNGS in suspected intracranial infectious pathogen diagnosis. Results showed a positivity rate of 71.67% (43 cases) with mNGS compared to 28.33% (17 cases) with traditional pathogen detection methods, demonstrating a significant difference (P < 0.05). The sensitivity of mNGS for detecting ICIs was 83.7%, significantly higher than the 34.88% observed with traditional methods (P < 0.05). The pathogen detection rate of mNGS was higher than traditional methods (P = 0.002), with an AUC of 0.856 (95% CI: 0.638–0.967), significantly greater than the AUC of 0.572 (95% CI: 0.350–0.792) for traditional methods (P < 0.05). mNGS successfully identified microorganisms such as Cryptococcus, Propionibacterium, Staphylococcus, Corynebacterium, Micrococcus, and Candida associated with ICIs. These findings underscore the clinical applicability of mNGS technology in analyzing the characteristics of HIV infection and ICI post-neurosurgical procedures. This technology enables more accurate diagnosis and treatment of ICIs, providing valuable insights for developing effective therapeutic strategies.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
宏基因组新一代测序对感染的临床价值
颅内感染(ICI)是神经外科手术后常见的严重并发症。宏基因组新一代测序(mNGS)技术可为颅内感染的临床诊断和治疗提供参考。本研究旨在探讨 mNGS 技术在分析人类免疫缺陷病毒(HIV)感染与神经外科手术后 ICI 的临床特征方面的应用价值。所有患者均接受了常规脑脊液分析和传统病原体检测,然后进行了 mNGS 基因组分析。以 ICI 的临床诊断为金标准,计算了两种检测方法的敏感性、特异性、阳性预测值和阴性预测值。构建了接收者操作特征曲线来评估曲线下面积(AUC),以评价 mNGS 在疑似颅内感染性病原体诊断中的临床价值。结果显示,mNGS 的阳性率为 71.67%(43 例),而传统病原体检测方法的阳性率为 28.33%(17 例),差异显著(P < 0.05)。mNGS 检测 ICI 的灵敏度为 83.7%,显著高于传统方法的 34.88%(P <0.05)。mNGS 的病原体检出率高于传统方法(P = 0.002),其 AUC 为 0.856(95% CI:0.638-0.967),明显高于传统方法的 AUC 0.572(95% CI:0.350-0.mNGS 成功鉴定了与 ICI 相关的微生物,如隐球菌、丙酸杆菌、葡萄球菌、棒状杆菌、微球菌和念珠菌。这些发现强调了 mNGS 技术在分析 HIV 感染特征和神经外科手术后 ICI 方面的临床适用性。这项技术能更准确地诊断和治疗 ICI,为制定有效的治疗策略提供宝贵的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.50
自引率
4.50%
发文量
131
审稿时长
43 weeks
期刊介绍: Open Life Sciences (previously Central European Journal of Biology) is a fast growing peer-reviewed journal, devoted to scholarly research in all areas of life sciences, such as molecular biology, plant science, biotechnology, cell biology, biochemistry, biophysics, microbiology and virology, ecology, differentiation and development, genetics and many others. Open Life Sciences assures top quality of published data through critical peer review and editorial involvement throughout the whole publication process. Thanks to the Open Access model of publishing, it also offers unrestricted access to published articles for all users.
期刊最新文献
An optimization method for measuring the stomata in cassava (Manihot esculenta Crantz) under multiple abiotic stresses. Assessing the proximate compositions of indigenous forage species in Yemen's pastoral rangelands. Comparative analysis of chloroplast genome of Lonicera japonica cv. Damaohua. Comparative transcriptome analysis of maize (Zea mays L.) seedlings in response to copper stress. Anti-γ-aminobutyric acid-B receptor autoimmune encephalitis with syncope as the initial symptom: Case report and literature review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1